Intriguingly, the combination of an anti-TNF monoclonal antibody to neutralize TNF plus etanercept, which additionally neutralizes LTα3, was effective in a case report of a patient with severe HLA-B27–associated arthropathy who had failed treatment with either agent alone (100). This evidence concerns the gene TNF and arthropathy.